Dusseldorf - Delayed Quote EUR

Karyopharm Therapeutics Inc (25K.DU)

Compare
0.5440
+0.0052
+(0.97%)
As of February 25 at 7:30:21 PM GMT+1. Market Open.

Key Executives

Karyopharm Therapeutics Inc

Description

Corporate Governance

Karyopharm Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 19, 2025 at 12:30 PM UTC

Karyopharm Therapeutics Inc Earnings Date

Recent Events